Sort
82,697 grants matching “vaccine development”
Nonhuman primate scientific research support component
$1,441,072Norman L Letvin · Duke University · UM1 · FY2014 · AI
Research Capacity Core
$1,440,934Ming Bo Huang · Morehouse School Of Medicine · U54 · FY2024 · MD
Molecular Basis of Francisella tularensis-Macrophage Interactions
$1,440,747Jean Celli · National Institute Of Allergy And Infectious Diseases · ZIA · FY2009 · AI
CELLULAR AND MOLECULAR STUDIES OF BONE MARROW TRANSPLANT
$1,440,655University Of Michigan At Ann Arbor · P01 · FY2003 · CA
New Strategies to Prevent Death from Influenza
$1,440,342Kendall A Smith · Weill Medical Coll Of Cornell Univ · U01 · FY2006 · AI
Immunology Quality Assessment Program
$1,440,222Jennifer McCalister · Duke University · N01 · FY2013 · AI
SPORE in Myeloid Malignancies
$1,440,214Benjamin Levine Ebert · Brigham And Women'S Hospital · P50 · FY2018 · CA
MFB: Massively parallel identification of translation regulatory sequences in human and viral mRNAs
$1,440,000Carson Thoreen · Yale University · · FY2024 · BIO
Genomic profiling of influenza infections to identify biomarkers of disease severity
$1,439,918Elodie Ghedin · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI
Host-pathogen interactions in filarial worm infections
$1,439,918Elodie Ghedin · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI
Bacteriophage-based approach for managing Shigella infections
$1,439,728Alexander Sulakvelidze · Intralytix, Inc. · U01 · FY2021 · AI
Novel vaccine adjuvants to counter bioterrorist threats
$1,439,143Nikolai Petrovsky · Flinders University Of South Australia · U01 · FY2008 · AI
Optimization and preclinical development of a TB Multiple Antigen Presenting System (MAPS) vaccine
$1,439,101Richard Malley · Boston Children'S Hospital · R01 · FY2018 · AI
Antigen Processing And Presentation In The Intestine
$1,438,892Brian Kelsall · National Institute Of Allergy And Infectious Diseases · Z01 · FY2008 · AI
Genetic and Environmental Modifiers Of Autoimmune Disease
$1,438,862Silvia Bolland · National Institute Of Allergy And Infectious Diseases · ZIA · FY2017 · AI
Adjuvant Enhanced Antiviral Immunity
$1,438,772Jeff C Fairman · Colby Pharmaceutical Company · U01 · FY2011 · AI
The origin, predictors, and immune correlates of viral rebound in orally SHIV infected infant monkeys
$1,438,174Sallie R. Permar · Weill Medical Coll Of Cornell Univ · P01 · FY2021 · AI
Comprehensive SDSU-UCSD Cancer Center Partnership (2 of 2)
$1,438,166Ana M Navarro · University Of California, San Diego · U54 · FY2009 · CA
PPG: HOST VIRUS INTERACTIONS IN HCoV-SARS INFECTIONS
$1,438,128University Of Iowa · P01 · FY2005 · AI
CTL and HIV Polymorphisms in Heterosexual Transmission
$1,437,996Eric Hunter · Emory University · R01 · FY2011 · AI
Immunologic control of HIV-1 through combination bNAbs and biologics.
$1,437,689Marina Caskey · Rockefeller University · U01 · FY2024 · AI
Preclinical Development of a Thermostable Trivalent Filovirus Vaccine
$1,437,310Axel T Lehrer · University Of Hawaii At Manoa · R01 · FY2017 · AI
Exploratory Human Trials of Combination Rectal Microbicides
$1,437,297Ian Michael McGowan · Magee-Women'S Res Inst And Foundation · U19 · FY2012 · AI
Directing Tumor-specific T cells to Tumors
$1,436,996Pawel Kalinski · University Of Pittsburgh At Pittsburgh · P01 · FY2013 · CA
Heterodimeric IL-15 in Cancer Immunotherapy
$1,436,310George N. Pavlakis · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA